We use cookies for a better user experience. Read our Privacy Policy

I Agree

Epinephrine Auto-Injector Market

Epinephrine Auto-Injector Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Epinephrine Auto-Injector: Introduction

  • Epinephrine, also called adrenaline, is a neurotransmitter and hormone produced by the adrenal glands. Epinephrine can also be utilized as a medication due to its numerous important functions. It is a class of medication called alpha- adrenergic agonists and beta-adrenergic agonists (sympathomimetic agents). It works by tightening the blood vessels and relaxing the muscles in the airways.
  • Epinephrine injection is indicated for the emergency treatment of allergic reactions including insect bite, anaphylaxis to stinging insects, diagnostic testing substances, drugs, foods, allergen immunotherapy and other allergens, as well as exercise-induced anaphylaxis or idiopathic anaphylaxis
  • Epinephrine auto-injector is as a prefilled automatic injection device containing a liquid to inject it intramuscularly or subcutaneously
  • EpiPen (Epinephrine in the form of auto-injector) has been available in the U.S since 1987

Key Drivers of Global Epinephrine Auto-Injector Market

  • Increase in the prevalence of allergies related to latex, food additives, dust, and food items and associated anaphylaxis across the globe is expected to drive the epinephrine auto-injector market during the forecast period
  • An increase in new product approvals and new product launches by key players in the market is also expected to drive the epinephrine auto-injector market during the forecast period
  • For instance, in August 2018, Teva Pharmaceuticals received approval from Food and Drug Administration to market its generic epinephrine auto-injector in two strengths 0.3 mg and 0.15 mg in the U.S.

0.30 mg Segment Expected to Expand Rapidly

  • Based on dosage, the global epinephrine auto-injector market can be divided into 0.15 mg, 0.30 mg, and 0.50 mg
  • The 0.30 mg segment of the global epinephrine auto-injector market is anticipated to expand at a rapid pace during the forecast period
  • Rise in the volume sales of generic epinephrine auto-injectors is expected to drive the segment during the forecast period

Home care Segment to Offer Attractive Opportunities

  • In terms of end-user, the global epinephrine auto-injector market can be classified into hospitals, clinics, home care, and others
  • The home care segment is expected to offer significant opportunities during the forecast period
  • Increase in the demand for self-management of anaphylaxis is expected to drive the home care segment during the forecast period

North America to Dominate the Global Epinephrine Auto-Injector Market

  • In terms of region, the global epinephrine auto-injector market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global epinephrine auto-injector market during the forecast period.
  • Increase in the number of people with various types of allergies, the availability of low-cost generic epinephrine auto-injectors, and high rate of adoption of generic epinephrine auto-injectors in the U.S. is expected to drive the epinephrine auto-injector market in the region during the forecast period
  • According to a study published in the JAMA Network 2019, about 10.8%, i.e. more than 26 million of adults in the U.S., are food allergic; however, approximately 19% of adults believe that they have a food allergy

Key Players Operating in Global Epinephrine Auto-Injector Market

The global epinephrine auto-injector market is concentrated due to the presence of international and few local players. Key players operating in the global epinephrine auto-injector market are:

  • Lincoln Medical Ltd.
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Adamis Pharmaceuticals Corp.
  • ALK-Abello AS
  • Amneal Pharmaceuticals Inc.
  • Bausch Health Companies, Inc.
  • kaleo Inc.

Global Epinephrine Auto-Injector Market: Research Scope

Global Epinephrine Auto-Injector Market, by Dosage

  • 0.15 mg
  • 0.30 mg
  • 0.50 mg

Global Epinephrine Auto-Injector Market, by Age Group

  • Under 6 Years Patients
  • 6 to 12 Years Patients
  • Over 12 Years Patients

Global Epinephrine Auto-Injector Market, by End-user

  • Hospitals
  • Clinics
  • Home Care
  • Others
Epinephrine Auto-Injector Market

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes

N/A

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

883

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved